My mother did clinical trials many years back for a serious illness. During the trials, she had some severe side effects including jaundice, heart palpitations and serious pain in her kidneys. The pain she went through was so severe she had to drop out of the trials.
ANVX has been conducting trials on 30 patients and all 30 patients were so pleased with the results they agreed to enroll in an extended study. Why. Two reasons: improvements in their cognitive capabilities (brain functions) and virtually no side effects. That in and of itself is very telling.
ANVX had everything going for it, great future, positive previous and current test results, professional team, increasing share price, management with integrity and honesty. For investors, it was the perfect place to be, the sweet spot at least until this past week.
This stock should be at $15.00 a share today, but there were those opportunists who in the financial world decided to orchestrate an all out assault on the stock and pound it into the ground. Perhaps they did it for some ulterior motive or hidden agendas and had to assemble a team of shorties to drive it down, and that they did.
The science didn't seem to matter today. Greed set in and the manipulators were able to drive it down. It may be that they want to see If they can drive the price down so it will fail, may want to protect other investments in competitor stocks, make profits on the way down then steal the shares from stock holders holding marginable securities who are forced to sell. We don't know why but do know that it was orchestrated by A particular individual, his cohorts and big money and their roles in making false statements, and bashing should really be investigated
This stock has tremendous potential to cure a disease that will likely affect every family in some time in their lives. Their drug currently has had the most positive results out of the entire group of candidates in this field of research. I can only hope that this stock will quickly recover from this setback and the management staff and highly skilled and accomplished researchers will continue to make progress in their trials and demonstrate that AVNX 273 drug and several of the others in their pipeline can reverse the effects and perhaps even cure AD and other dreaded diseases. Good luck to all sincere and worthy investors who believe in this company and continue to support it. God Bless You All!
